Analyst Price Target is $5.25
▲ +40.00% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for INVO Bioscience in the last 3 months. The average price target is $5.25, with a high forecast of $5.25 and a low forecast of $5.25. The average price target represents a 40.00% upside from the last price of $3.75.
Current Consensus is
The current consensus among 2 investment analysts is to buy stock in INVO Bioscience.